The changing epidemiology and demography of cystic fibrosis

Presse Medicale

Volumn 46, Issue 6P2, 2017, Pages e87-e95

  Stephenson, Anne L ^a,c   Stanojevic, Sanja ^b,c   Sykes, Jenna ^a   Burgel, Pierre Regis ^d,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BURKHOLDERIA CEPACIA INFECTION; CYSTIC FIBROSIS; DIABETES MELLITUS; FORCED EXPIRATORY VOLUME; HUMAN; LIFE EXPECTANCY; LONG TERM SURVIVAL; LUNG TRANSPLANTATION; MALNUTRITION; MORTALITY RATE; NUTRITIONAL SUPPORT; OVERALL SURVIVAL; PROGNOSIS; PSEUDOMONAS INFECTION; RACE DIFFERENCE; SEX RATIO; SHORT SURVEY; SOCIOECONOMICS; ADOLESCENT; ADULT; CANADA; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; DEMOGRAPHY; EUROPE; INFANT; INTERDISCIPLINARY COMMUNICATION; INTERSECTORAL COLLABORATION; MORTALITY; NEWBORN; NEWBORN SCREENING; PRESCHOOL CHILD; REGISTER; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; CANADA; CHILD; CHILD, PRESCHOOL; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DEMOGRAPHY; EUROPE; HUMANS; INFANT; INFANT, NEWBORN; INTERDISCIPLINARY COMMUNICATION; INTERSECTORAL COLLABORATION; LIFE EXPECTANCY; NEONATAL SCREENING; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 85019879156     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2017.04.012     Document Type: Short Survey

References (60)

1. Knapp, E.A., Fink, A.K., Goss, C.H., Sewall, A., Ostrenga, J., Dowd, C., et al. The cystic fibrosis foundation patient registry. Design and methods of a national observational disease registry. Ann Am Thorac Soc 13 (2016), 1173–1179.
2. Fredj, S.H., Messaoud, T., Templin, C., des Georges, M., Fattoum, S., Claustres, M., Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia. Gene Test Mol Biomarkers 13 (2009), 577–581.
3. Stewart, C., Pepper, M.S., Cystic fibrosis on the African continent. Gene Med 18 (2016), 653–662.
4. Stephenson, A.L., Tom, M., Berthiaume, Y., Singer, L.G., Aaron, S.D., Whitmore, G.A., et al. A contemporary survival analysis of individuals with cystic fibrosis: a cohort study. Eur Respir J 45 (2015), 670–679.
5. MacKenzie, T., Gifford, A.H., Sabadosa, K.A., Quinton, H.B., Knapp, E.A., Goss, C.H., et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic fibrosis foundation patient registry. Ann Intern Med 161 (2014), 233–241.
6. FitzSimmons, S.C., The changing epidemiology of cystic fibrosis. J Pediatr 122 (1993), 1–9.
7. Canada CF. Cystic fibrosis registry report. Canada; 2014.
8. Foundation, C.F., Annual registry report. 2015, Bethesda, USA.
9. Burgel, P.R., Bellis, G., Olesen, H.V., Viviani, L., Zolin, A., Blasi, F., et al. Future trends in cystic fibrosis demography in 34 European countries. Eur Respir J 46 (2015), 133–141.
10. Urquhart, D.S., Thia, L.P., Francis, J., Prasad, S.A., Dawson, C., Wallis, C., et al. Deaths in childhood from cystic fibrosis: 10-year analysis from two London specialist centres. Arch Dis Childhood 98 (2013), 123–127.
11. Elborn, J.S., Bell, S.C., Madge, S.L., Burgel, P.R., Castellani, C., Conway, S., et al. Report of the European respiratory society/European cystic fibrosis society task force on the care of adults with cystic fibrosis. Eur Respir J 47 (2016), 420–428.
12. Quintana-Gallego, E., Ruiz-Ramos, M., Delgado-Pecellin, I., Calero, C., Soriano, J.B., Lopez-Campos, J.L., Mortality from cystic fibrosis in Europe: 1994–2010. Pediatr Pulmonol 51 (2016), 133–142.
13. Alicandro, G., Frova, L., Di Fraia, G., Colombo, C., Cystic fibrosis mortality trend in Italy from 1970 to 2011. J Cyst Fibros 14 (2015), 267–274.
14. Fogarty, A., Hubbard, R., Britton, J., International comparison of median age at death from cystic fibrosis. Chest 117 (2000), 1656–1660.
15. Hurley, M.N., McKeever, T.M., Prayle, A.P., Fogarty, A.W., Smyth, A.R., Rate of improvement of CF life expectancy exceeds that of general population – observational death registration study. J Cyst Fibros 13 (2014), 410–415.
16. Hoo, Z.H., Wildman, M.J., Teare, M.D., Exploration of the impact of “mild phenotypes” on median age at death in the UK CF registry. Respir Med 108 (2014), 716–721.
17. Corey, M., McLaughlin, F.J., Williams, M., Levison, H., A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 41 (1988), 583–591.
18. Jackson, A.D., Daly, L., Kelleher, C., Marshall, B.C., Quinton, H.B., Foley, L., et al. The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited. J Cyst Fibros 10 (2011), 62–65.
19. Sykes, J., Stanojevic, S., Goss, C.H., Quon, B.S., Marshall, B.C., Petren, K., et al. A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts. J Clin Epidemiol 70 (2016), 206–213.
20. Stephenson, A.L., Sykes, J., Stanojevic, S., Quon, B.S., Marshall, B.C., Petren, K., et al. Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study. Ann Intern Med, 2017.
21. Kerem, E., Reisman, J., Corey, M., Canny, G.J., Levison, H., Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326 (1992), 1187–1191.
22. Mayer-Hamblett, N., Rosenfeld, M., Emerson, J., Goss, C.H., Aitken, M.L., Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 166 (2002), 1550–1555.
23. George, P.M., Banya, W., Pareek, N., Bilton, D., Cullinan, P., Hodson, M.E., et al. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ (Clin Res Ed), 342, 2011, d1008.
24. McKone, E.F., Goss, C.H., Aitken, M.L., CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest 130 (2006), 1441–1447.
25. Lai, H.J., Cheng, Y., Cho, H., Kosorok, M.R., Farrell, P.M., Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 159 (2004), 537–546.
26. Liou, T.G., Adler, F.R., Fitzsimmons, S.C., Cahill, B.C., Hibbs, J.R., Marshall, B.C., Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 153 (2001), 345–352.
27. Kulich, M., Rosenfeld, M., Goss, C.H., Wilmott, R., Improved survival among young patients with cystic fibrosis. J Pediatr 142 (2003), 631–636.
28. Milla, C.E., Billings, J., Moran, A., Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28 (2005), 2141–2144.
29. Britton, J.R., Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ (Clin Res Ed) 298 (1989), 483–487.
30. Corey, M., Farewell, V., Determinants of mortality from cystic fibrosis in Canada, 1970–1989. Am J Epidemiol 143 (1996), 1007–1017.
31. Mahadeva, R., Webb, K., Westerbeek, R.C., Carroll, N.R., Dodd, M.E., Bilton, D., et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ (Clin Res Ed) 316 (1998), 1771–1775.
32. Nkam, L., Lambert, J., Latouche, A., Bellis, G., Burgel, P.R., Hocine, M.N., A 3-year prognostic score for adults with cystic fibrosis. J Cyst Fibros, 2017 [In press].
33. Aaron, S.D., Stephenson, A.L., Cameron, D.W., Whitmore, G.A., A statistical model to predict 1-year risk of death in patients with cystic fibrosis. J Clin Epidemiol 68 (2015), 1336–1345.
34. Hodson, M.E., Simmonds, N.J., Warwick, W.J., Tullis, E., Castellani, C., Assael, B., et al. An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years. J Cyst Fibros 7 (2008), 537–542.
35. Nick, J.A., Chacon, C.S., Brayshaw, S.J., Jones, M.C., Barboa, C.M., St Clair, C.G., et al. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 182 (2010), 614–626.
36. Rosenfeld, M., Davis, R., FitzSimmons, S., Pepe, M., Ramsey, B., Gender gap in cystic fibrosis mortality. Am J Epidemiol 145 (1997), 794–803.
37. Dodge, J.A., Lewis, P.A., Stanton, M., Wilsher, J., Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J 29 (2007), 522–526.
38. Chamnan, P., Shine, B.S., Haworth, C.S., Bilton, D., Adler, A.I., Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 33 (2010), 311–316.
39. Sawicki, G.S., Signorovitch, J.E., Zhang, J., Latremouille-Viau, D., von Wartburg, M., Wu, E.Q., et al. Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution. Pediatr Pulmonol 47 (2012), 44–52.
40. Martin, C., Hamard, C., Kanaan, R., Boussaud, V., Grenet, D., Abely, M., et al. Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!. J Cyst Fibros 15 (2016), 204–212.
41. Chotirmall, S.H., Smith, S.G., Gunaratnam, C., Cosgrove, S., Dimitrov, B.D., O'Neill, S.J., et al. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med 366 (2012), 1978–1986.
42. Demko, C.A., Byard, P.J., Davis, P.B., Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 48 (1995), 1041–1049.
43. Lewin, L.O., Byard, P.J., Davis, P.B., Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 43 (1990), 125–131.
44. Marshall, B.C., Butler, S.M., Stoddard, M., Moran, A.M., Liou, T.G., Morgan, W.J., Epidemiology of cystic fibrosis-related diabetes. J Pediatr 146 (2005), 681–687.
45. Viviani, L., Bossi, A., Assael, B.M., Absence of a gender gap in survival. An analysis of the Italian registry for cystic fibrosis in the paediatric age. J Cyst Fibros 10 (2011), 313–317.
46. Moran, A., Dunitz, J., Nathan, B., Saeed, A., Holme, B., Thomas, W., Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes care 32 (2009), 1626–1631.
47. Fogarty, A.W., Britton, J., Clayton, A., Smyth, A.R., Are measures of body habitus associated with mortality in cystic fibrosis?. Chest 142 (2012), 712–717.
48. O'Connor, G.T., Quinton, H.B., Kneeland, T., Kahn, R., Lever, T., Maddock, J., et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 111 (2003), e333–e339.
49. Schechter, M.S., Shelton, B.J., Margolis, P.A., Fitzsimmons, S.C., The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 163 (2001), 1331–1337.
50. Barr, H.L., Britton, J., Smyth, A.R., Fogarty, A.W., Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross-sectional study. BMJ (Clin Res Ed), 343, 2011, d4662.
51. Meachery, G., De, S.A., Nicholson, A., Parry, G., Hasan, A., Tocewicz, K., et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 63 (2008), 725–731.
52. Gruber, S., Eiwegger, T., Nachbaur, E., Tiringer, K., Aigner, C., Jaksch, P., et al. Lung transplantation in children and young adults: a 20-year single-centre experience. Eur Respir J 40 (2012), 462–469.
53. Boussaud, V., Guillemain, R., Grenet, D., Coley, N., Souilamas, R., Bonnette, P., et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 63 (2008), 732–737.
54. Thabut, G., Christie, J.D., Mal, H., Fournier, M., Brugiere, O., Leseche, G., et al. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. Am J Respir Crit Care Med 187 (2013), 1335–1340.
55. Weiss, E.S., Allen, J.G., Modi, M.N., Merlo, C.A., Conte, J.V., Shah, A.S., Lung transplantation in older patients with cystic fibrosis: analysis of UNOS data. J Heart Lung Transplant 28 (2009), 135–140.
56. Stephenson, A.L., Sykes, J., Berthiaume, Y., Singer, L.G., Aaron, S.D., Whitmore, G.A., et al. Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis. J Heart Lung Transpl 34 (2015), 1139–1145.
57. Milla, C.E., Warwick, W.J., Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 113 (1998), 1230–1234.
58. Aurora, P., Wade, A., Whitmore, P., Whitehead, B., A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J 16 (2000), 1056–1060.
59. Hofer, M., Benden, C., Inci, I., Schmid, C., Irani, S., Speich, R., et al. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant 28 (2009), 334–339.
60. Hofer, M., Schmid, C., Benden, C., Speich, R., Inci, I., Weder, W., et al. Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation. J Cyst Fibros 11 (2012), 131–136.